Jim Zarroli
Jim Zarroli is an NPR correspondent based in New York. He covers economics and business news.
Over the years, he has reported on recessions and booms, crashes and rallies, and a long string of tax dodgers, insider traders, and Ponzi schemers. Most recently, he has focused on trade and the job market. He also worked as part of a team covering President Trump's business interests.
Before moving into his current role, Zarroli served as a New York-based general assignment reporter for NPR News. While in this position, he reported from the United Nations and was also involved in NPR's coverage of Hurricane Katrina, the London transit bombings, and the Fukushima earthquake.
Before joining NPR in 1996, Zarroli worked for the Pittsburgh Press and wrote for various print publications.
He lives in Manhattan, loves to read, and is a devoted (but not at all fast) runner.
Zarroli grew up in Wilmington, Delaware, in a family of six kids and graduated from Pennsylvania State University.
-
More than 150 business leaders released a letter calling on President Trump to start the transition process, given the urgent need to tackle the fallout from the coronavirus pandemic.
-
Treasury Secretary Steve Mnuchin wants to let the emergency loan programs expire at the end of the year. Federal Reserve Chair Jerome Powell says that's too soon.
-
The Fed will comply with a request from the Treasury Department to wind down coronavirus emergency lending programs after the central bank had earlier objected to the move.
-
The president-elect can undo many of Trump's tariffs with the stroke of a pen, but he's unlikely to do so now that the tenor of the U.S.-China relationship has changed.
-
Judy Shelton, the controversial nominee to the Federal Reserve's Board of Governors, failed to advance for a vote in the Senate, delivering Republicans and the Trump administration a major setback.
-
Investors were also reassured by comments from two Biden advisers that no nationwide COVID-19 lockdowns are being contemplated.
-
Stocks soared to record highs after drugmaker Pfizer announced its experimental coronavirus vaccine was more than 90% effective, providing a major dose of hope for the global economy.
-
Stocks surged after Pfizer said its experimental vaccine was more than 90% effective and after former Vice President Joe Biden was elected president.
-
Investors are betting on at least two more years of divided government, spurring the best weekly stock gains in months.
-
Stocks have traditionally done well with a Democrat in the White House and Congress under Republican control.